GlassScriptPhysician profile
Michael M Maddox
NPI 1356503833
$11,634.23
in general payments reported to CMS, 2019-2025
19 companies · $445 in 2025
The $445 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,859 · 2020: $154 · 2021: $84.20 · 2022: $158 · 2023: $3,742 · 2024: $1,192 · 2025: $445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,984 · Travel and Lodging: $1,902 · Honoraria: $250 · Education: $220 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,983.68 |
| Travel and Lodging | $1,901.91 |
| Honoraria | $250.00 |
| Education | $220.10 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,379.97 | 2019-2024 | Da Vinci Surgical System |
| Boston Scientific Corporation | $3,359.18 | 2019-2024 | Ams 700, Lithovue, Advance Xp |
| Lumenis, INC | $1,500.00 | 2019 | |
| Cook Medical LLC | $382.41 | 2019-2024 | Resonance, Cook, Fiber Dust |
| Karl Storz Endoscopy-America | $288.05 | 2020-2023 | N.A. |
| Astellas Pharma US INC | $285.03 | 2019-2024 | |
| Cook Incorporated | $250.00 | 2023 | |
| Photocure INC | $239.47 | 2024-2025 | Cysview |
| Urogen Pharma, INC. | $202.58 | 2022-2025 | Jelmyto |
| Kerecis Limited | $171.68 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Olympus America INC. | $140.47 | 2024 | Itind System |
| Medtronic, INC. | $122.99 | 2024 | Interstim |
| Revance Therapeutics, INC. | $61.72 | 2025 | Daxxify |
| Myriad Genetic Laboratories, INC. | $54.60 | 2023 | Prolaris |
| Progenics Pharmaceuticals, INC. | $52.85 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $47.90 | 2022 | |
| Calyxo, INC. | $44.11 | 2025 | Cvac Aspiration System |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Coloplast Corp | $16.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Maddox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.